The Translational Biomarkers in Aging and Dementia (TRIAD) cohort focuses on advanced personalized and preclinical dementia diagnosis. We study dementia markers and their progression from pre-symptomatic stages to the onset of the Alzheimer’s disease or other types of dementia. The TRIAD cohort assesses the trajectory of multiple imaging and fluid biomarkers in clinical populations and serves as a benchmark for testing novel biomarkers of dementia.
Neurologist and Associate Professor, McGill University, MontrealDirector of the McGill Center for Studies in Aging
NeurologistDirector, Alzheimer Disease Research Unit
All the data collected under the TRIAD cohort is governed by the policies set by the Research Ethics Board Office of the McGill University, Montreal and the Douglas Research Center, Verdun. If you are a researcher and would like to access the TRIAD data for research purpose, please submit a data share request via our data share page.
If you would like to participate in our cohort (or to be part of our cohort) or if you have any inquiries.